Incorporation of heparin into biomaterials

Acta Biomaterialia

Volumn 10, Issue 4, 2014, Pages 1581-1587

  Sakiyama Elbert, Shelly E ^a  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Affinity delivery system; Drug delivery; Heparin mimetics; Self assembling materials

Indexed keywords

BIOMATERIALS; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; PROTEINS; SCAFFOLDS (BIOLOGY); SELF ASSEMBLY; TARGETED DRUG DELIVERY;

AFFINITY DELIVERY SYSTEM; CELL SURFACE RECEPTORS; DELIVERY SYSTEMS; DRUG DELIVERY APPLICATIONS; GROWTH FACTOR; HEPARIN-MIMETIC; MIMETICS; POLYMER NETWORKS; SELF-ASSEMBLING MATERIALS; THROMBOGENICITY;

POLYSACCHARIDES;

ALBUMIN; BIOMATERIAL; CELL SURFACE RECEPTOR; COLLAGEN; GLYCINE; GROWTH FACTOR; HEPARIN; POLYMER;

BIODEGRADATION; CELL DIFFERENTIATION; CONJUGATION; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; HUMAN; HYDROGEL; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; THROMBOGENICITY;

AFFINITY DELIVERY SYSTEM; DRUG DELIVERY; HEPARIN-MIMETICS; SELF-ASSEMBLING MATERIALS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMIMETIC MATERIALS; CELL DIFFERENTIATION; DRUG DELIVERY SYSTEMS; HEPARIN; HUMANS; POLYMERS;

EID: 84896391569     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.08.045     Document Type: Review

References (94)

1. D.L. Rabenstein Heparin and heparan sulfate: Structure and function Nat Prod Rep 19 2002 312 331
2. H. Lodish, A. Berk, C. Kaiser, M. Krieger, M. Scott, and A. Bretcher et al. Molecular cell biology 2008 WH Freeman and Co. New York
3. S. Sakiyama-Elbert Drug delivery via heparin conjugates P. Ducheyne, K.E. Healy, D.W. Hutmacher, D.W. Grainger, C.J. Kirkpatrick, Comprehensive biomaterials 2011 Elsevier Amsterdam 333 338
4. D. Edgar, R. Timpl, and H. Thoenen The heparin-binding domain of laminin is responsible for its effects on neurite outgrowth and neuronal survival EMBO J 3 1984 1463 1468
5. S.L. Rogers, J.B. McCarthy, S.L. Palm, L.T. Furcht, and P.C. Letourneau Neuron-specific interactions with two neurite-promoting fragments of fibronectin J Neurosci 5 1985 369 378
6. M. Ishihara, P.N. Shaklee, Z. Yang, W. Liang, Z. Wei, and R.J. Stack et al. Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor Glycobiology 4 1994 451 458
7. J. Choay, M. Petitou, J.C. Lormeau, P. Sinay, B. Casu, and G. Gatti Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity Biochem Biophys Res Commun 116 1983 492 499
8. V.L. Gott, J.D. Whiffen, and R.C. Dutton Heparin bonding on colloidal graphite surfaces Science 142 1963 1297 1298
9. G.A. Grode, S.J. Anderson, H.M. Grotta, and R.D. Falb Nonthrombogenic materials via a simple coating process Trans Am Soc Artif Intern Organs 15 1969 1 6
10. R.I. Leininger, C.W. Cooper, R.D. Falb, and G.A. Grode Nonthrombogenic plastic surfaces Science 152 1966 1625 1626
11. O. Larm, R. Larsson, and P. Olsson A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue Biomater Med Devices Artif Organs 11 1983 161 173
12. J.A. Hubbell, W.W. Muir, and J.S. Gaynor Cardiovascular effects of thoracic compression in horses subjected to euthanasia Equine Vet J 25 1993 282 284
13. P. Olsson, J. Sanchez, T.E. Mollnes, and J. Riesenfeld On the blood compatibility of end-point immobilized heparin J Biomater Sci Polym Ed 11 2000 1261 1273
14. M.C. Tanzi Bioactive technologies for hemocompatibility Expert Rev Med Devices 2 2005 473 492
15. S.W. Jordan, and E.L. Chaikof Novel thromboresistant materials J Vasc Surg 45 Suppl. A 2007 A104 A115
16. P.C. Begovac, R.C. Thomson, J.L. Fisher, A. Hughson, and A. Gallhagen Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization Eur J Vasc Endovasc Surg 25 2003 432 437
17. C. Devine, and C. McCollum Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial J Vasc Surg 40 2004 924 931
18. C. Saitow, D.L. Kaplan, and J.J. Castellot Heparin stimulates elastogenesis: Application to silk-based vascular grafts Matrix Biol 30 2011 346 355
19. S.R. Nelson, N.M. DeSouza, and D.J. Allison Endovascular stents and stent-grafts: Is heparin coating desirable? Cardiovas Intervent Radiol 23 2000 252 255
20. R. Langer Drug delivery and targeting Nature 392 1998 5 10
21. A.D. Cardin, R.L. Jackson, D.A. Sparrow, and J.T. Sparrow Interaction of glycosaminoglycans with lipoproteins Ann NY Acad Sci 556 1989 186 193
22. D.M. Ornitz, A. Yayon, J.G. Flanagan, C.M. Svahn, E. Levi, and P. Leder Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells Mol Cell Biol 12 1992 240 247
23. S. Kanzaki, T. Takahashi, T. Kanno, W. Ariyoshi, K. Shinmyouzu, and T. Tujisawa et al. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor J Cell Physiol 216 2008 844 850
24. D.S. Bramono, S. Murali, B. Rai, L. Ling, W.T. Poh, and Z.X. Lim et al. Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2) Bone 50 2012 954 964
25. M. Klagsbrun The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix Curr Opin Cell Biol 2 1990 857 863
26. L.F. Lin, T.J. Zhang, F. Collins, and L.G. Armes Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor J Neurochem 63 1994 758 768
27. M. Lyon, G. Rushton, and J.T. Gallagher The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific J Biol Chem 272 1997 18000 18006
28. S. Tessler, P. Rockwell, D. Hicklin, T. Cohen, B.Z. Levi, and L. Witte et al. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors J Biol Chem 269 1994 12456 12461
29. J.J. Lee, S.C. Ekker, D.P. von Kessler, J.A. Porter, B.I. Sun, and P.A. Beachy Autoproteolysis in hedgehog protein biogenesis Science 266 1994 1528 1537
30. K.S. Rostand, and J.D. Esko Microbial adherence to and invasion through proteoglycans Infect Immun 65 1997 1 8
31. E.R. Edelman, E. Mathiowitz, R. Langer, and M. Klagsbrun Controlled and modulated release of basic fibroblast growth factor Biomaterials 12 1991 619 626
32. E.R. Edelman, M.A. Nugent, L.T. Smith, and M.J. Karnovsky Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries J Clin Invest 89 1992 465 473
33. R.J. Laham, F.W. Sellke, E.R. Edelman, J.D. Pearlman, J.A. Ware, and D.L. Brown et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial Circulation 100 1999 1865 1871
34. M. Ruel, R.J. Laham, J.A. Parker, M.J. Post, J.A. Ware, and M. Simons et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein J Thorac Cardiovasc Surg 124 2002 28 34
35. W.E. Hennink, J. Feijen, C.D. Ebert, and S.W. Kim Covalently bound conjugates of albumin and heparin: Synthesis, fractionation and characterization Thromb Res 29 1983 1 13
36. H.F. Cremers, G. Kwon, Y.H. Bae, S.W. Kim, R. Verrijk, and H.P. Noteborn et al. Preparation and characterization of albumin-heparin microspheres Biomaterials 15 1994 38 48
37. M.J. Wissink, R. Beernink, A.A. Poot, G.H. Engbers, T. Beugeling, and W.G. van Aken et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices J Control Release 64 2000 103 114
38. M.J. Wissink, R. Beernink, N.M. Scharenborg, A.A. Poot, G.H. Engbers, and T. Beugeling et al. Endothelial cell seeding of (heparinized) collagen matrices: Effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors J Control Release 67 2000 141 155
39. P.B. van Wachem, J.A. Plantinga, M.J. Wissink, R. Beernink, A.A. Poot, and G.H. Engbers et al. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading J Biomed Mater Res 55 2001 368 378
40. J.S. Pieper, T. Hafmans, P.B. van Wachem, M.J. van Luyn, L.A. Brouwer, and J.H. Veerkamp et al. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats J Biomed Mater Res 62 2002 185 194
41. O. Jeon, S.W. Kang, H.W. Lim, J. Hyung Chung, and B.S. Kim Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 27 2006 1598 1607
42. O. Jeon, S.J. Song, S.W. Kang, A.J. Putnam, and B.S. Kim Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold Biomaterials 28 2007 2763 2771
43. L.S. Liu, C.K. Ng, A.Y. Thompson, J.W. Poser, and R.C. Spiro Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2) J Biomed Mater Res 62 2002 128 135
44. S. Wang, O.P. Oommen, H. Yan, and O.P. Varghese Mild and efficient strategy for site-selective aldehyde modification of glycosaminoglycans: Tailoring hydrogels with tunable release of growth factor Biomacromolecules 14 2013 2427 2432
45. X.Z. Shu, Y. Liu, Y. Luo, M.C. Roberts, and G.D. Prestwich Disulfide cross-linked hyaluronan hydrogels Biomacromolecules 3 2002 1304 1311
46. S.S. Cai, Y.C. Liu, X.Z. Shu, and G.D. Prestwich Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor Biomaterials 26 2005 6054 6067
47. G. Tae, Y.J. Kim, W.I. Choi, M. Kim, P.S. Stayton, and A.S. Hoffman Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules Biomacromolecules 8 2007 1979 1986
48. W.I. Choi, M. Kim, G. Tae, and Y.H. Kim Sustained release of human growth hormone from heparin-based hydrogel Biomacromolecules 9 2008 1698 1704
49. J.S. McGonigle, G. Tae, P.S. Stayton, A.S. Hoffman, and M. Scatena Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels J Biomater Sci Polym Ed 19 2008 1021 1034
50. P. McCaldon, and P. Argos Oligopeptide biases in protein sequences and their use in predicting protein coding regions in nucleotide sequences Proteins 4 1988 99 122
51. N. Yamaguchi, and K.L. Kiick Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels Biomacromolecules 6 2005 1921 1930
52. T. Nie, A. Baldwin, N. Yamaguchi, and K.L. Kiick Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems J Control Release 122 2007 287 296
53. P. Bulpitt, and D. Aeschlimann New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels J Biomed Mater Res 47 1999 152 169
54. G. Tae, M. Scatena, P.S. Stayton, and A.S. Hoffman PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor J Biomater Sci Polym Ed 17 2006 187 197
55. S.E. Sakiyama-Elbert, and J.A. Hubbell Development of fibrin derivatives for controlled release of heparin-binding growth factors J Control Release 65 2000 389 402
56. S.E. Sakiyama-Elbert, and J.A. Hubbell Controlled release of nerve growth factor from a heparin-containing fibrin-based cell in growth matrix J Control Release 69 2000 149 158
57. A.B. Pratt, F.E. Weber, H.G. Schmoekel, R. Muller, and J.A. Hubbell Synthetic extracellular matrices for in situ tissue engineering Biotechnol Bioeng 86 2004 27 36
58. S. Thomopoulos, R. Das, M.J. Silva, S. Sakiyama-Elbert, F.L. Harwood, and E. Zampiakis et al. Enhanced flexor tendon healing through controlled delivery of PDGF-BB J Orthop Res 27 2009 1209 1215
59. S. Thomopoulos, M. Zaegel, R. Das, F.L. Harwood, M.J. Silva, and D. Amiel et al. PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling J Orthop Res 25 2007 1358 1368
60. R.H. Gelberman, S. Thomopoulos, S.E. Sakiyama-Elbert, R. Das, and M.J. Silva The early effects of sustained platelet-derived growth factor administration on the functional and structural properties of repaired intrasynovial flexor tendons: An in vivo biomechanic study at 3 weeks in canines J Hand Surg Am 32 2007 373 379
61. D.J. Maxwell, B.C. Hicks, S. Parsons, and S.E. Sakiyama-Elbert Development of rationally designed affinity-based drug delivery systems Acta Biomater 1 2005 101 113
62. M.D. Wood, and S.E. Sakiyama-Elbert Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems J Biomed Mater Res A 84 2008 300 312
63. R. Wieduwild, M. Tsurkan, K. Chwalek, P. Murawala, M. Nowak, and U. Freudenberg et al. Minimal peptide motif for non-covalent peptide-heparin hydrogels J Am Chem Soc 135 2013 2919 2922
64. A.C. Lee, V.M. Yu, J.B. Lowe, M.J. Brenner, D.A. Hunter, and S.E. Mackinnon et al. Controlled release of nerve growth factor enhances sciatic nerve regeneration Exp Neurol 184 2003 295 303
65. M.D. Wood, A.M. Moore, D.A. Hunter, S. Tuffaha, G.H. Borschel, and S.E. Mackinnon et al. Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration Acta Biomater 5 2009 959 968
66. P.J. Johnson, S.R. Parker, and S.E. Sakiyama-Elbert Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury Biotechnol Bioeng 104 2009 1207 1214
67. S.J. Taylor, E.S. Rosenzweig, J.W. McDonald, and S.E. Sakiyama-Elbert Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury J Control Release 113 2006 226 235
68. G.A. Hudalla, J.T. Koepsel, and W.L. Murphy Surfaces that sequester serum-borne heparin amplify growth factor activity Adv Mater 23 2011 5415 5418
69. G.A. Hudalla, N.A. Kouris, J.T. Koepsel, B.M. Ogle, and W.L. Murphy Harnessing endogenous growth factor activity modulates stem cell behavior Integr Biol 3 2011 832 842
70. S.B. Seif-Naraghi, D. Horn, P.J. Schup-Magoffin, and K.L. Christman Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor Acta Biomater 8 2012 3695 3703
71. H.D. Maynard, and J.A. Hubbell Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor Acta Biomater 1 2005 451 459
72. K.L. Christman, V. Vazquez-Dorbatt, E. Schopf, C.M. Kolodziej, R.C. Li, and R.M. Broyer et al. Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer J Am Chem Soc 130 2008 16585 16591
73. T.H. Nguyen, S.H. Kim, C.G. Decker, D.Y. Wong, J.A. Loo, and H.D. Maynard A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor Nat Chem 5 2013 221 227
74. S.M. Willerth, A. Rader, and S.E. Sakiyama-Elbert The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds Stem Cell Res 1 2008 205 218
75. P.J. Johnson, A. Tatara, A. Shiu, and S.E. Sakiyama-Elbert Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI Cell Transplant 19 2010 89 101
76. H.J. Lam, S. Patel, A. Wang, J. Chu, and S. Li In vitro regulation of neural differentiation and axon growth by growth factors and bioactive nanofibers Tissue Eng A 16 2010 2641 2648
77. N. Sangaj, P. Kyriakakis, D. Yang, C.W. Chang, G. Arya, and S. Varghese Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells Biomacromolecules 11 2010 3294 3300
78. L.W. Chow, L.J. Wang, D.B. Kaufman, and S.I. Stupp Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets Biomaterials 31 2010 6154 6161
79. Y.C. Kuo, and C.T. Wang Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface Colloids Surf B Biointerfaces 100 2012 9 15
80. C.W. Chang, Y. Hwang, D. Brafman, T. Hagan, C. Phung, and S. Varghese Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells Biomaterials 34 2013 912 921
81. M. Kim, Y.H. Kim, and G. Tae Human mesenchymal stem cell culture on heparin-based hydrogels and the modulation of interactions by gel elasticity and heparin amount Acta Biomater 9 2013 7833 7844
82. B.L. Seal, and A. Panitch Physical polymer matrices based on affinity interactions between peptides and polysaccharides Biomacromolecules 4 2003 1572 1582
83. L. Zhang, E.M. Furst, and K.L. Kiick Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions J Control Release 114 2006 130 142
84. K. Rajangam, H.A. Behanna, M.J. Hui, X.Q. Han, J.F. Hulvat, and J.W. Lomasney et al. Heparin binding nanostructures to promote growth of blood vessels Nano Lett 6 2006 2086 2090
85. L.W. Chow, R. Bitton, M.J. Webber, D. Carvajal, K.R. Shull, and A.K. Sharma et al. A bioactive self-assembled membrane to promote angiogenesis Biomaterials 32 2011 1574 1582
86. U. Freudenberg, A. Hermann, P.B. Welzel, K. Stirl, S.C. Schwarz, and M. Grimmer et al. A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases Biomaterials 30 2009 5049 5060
87. M.V. Tsurkan, K. Chwalek, S. Prokoph, A. Zieris, K.R. Levental, and U. Freudenberg et al. Defined polymer-peptide conjugates to form cell-instructive starPEG-heparin matrices in situ Adv Mater 25 2013 2606 2610
88. A. Zieris, K. Chwalek, S. Prokoph, K.R. Levental, P.B. Welzel, and U. Freudenberg et al. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels J Control Release 156 2011 28 36
89. M.V. Tsurkan, K.R. Levental, U. Freudenberg, and C. Werner Enzymatically degradable heparin-polyethylene glycol gels with controlled mechanical properties Chem Commun (Camb) 46 2010 1141 1143
90. A. Zieris, S. Prokoph, K.R. Levental, P.B. Welzel, M. Grimmer, and U. Freudenberg et al. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis Biomaterials 31 2010 7985 7994
91. M.V. Tsurkan, K. Chwalek, K.R. Levental, U. Freudenberg, and C. Werner Modular starPEG-heparin gels with bifunctional peptide linkers Macromol Rapid Commun 31 2010 1529 1533
92. L. Baumann, S. Prokoph, C. Gabriel, U. Freudenberg, C. Werner, and A.G. Beck-Sickinger A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro J Control Release 162 2012 68 75
93. U. Freudenberg, J.-U. Sommer, K.R. Levental, P.B. Welzel, A. Zieris, and K. Chwalek et al. Using mean field theory to guide biofunctional materials design Adv Funct Mater 22 2012 1391 1398
94. L. LeBrun, and R.J. Linhardt Degradation of heparan sulfate with heparin lyases R. Iozzo, Proteoglycan protocols 2001 Humana Press Totowa, NJ 353 361